2002, Clinical Trials, Programs and Safety

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2002

Clinical Trials

Programs

Safety

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials

Clinical Trials Therapy Research and Development DEA

New Frontiers in the Law of Psychedelics

Cannabis Law Report

JULY 9, 2021

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law

Law Therapy Clinical Trials Research and Development

Medical Cannabis Brief

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

New Frontiers in the Law of Psychedelics

Stay Connected